CYBN (Cybin Corp) רווחיות גולמית

The gross margin value reflects market expectations, where the figure 0.00 expresses the metric level for Cybin Inc. (CYBN). This trend is driven by strict control over substance delivery and the diversification of laboratories. Revenues are projected from the sale of innovative psychedelics for the treatment of depression. However, the capitalization is based on patents, the success of which depends directly on the final decisions of government regulators.
פילוחי מדדים פיננסיים ומדדי שוק עבור Cybin Inc. (CYBN)

Gross margin reflects the portion of revenue remaining after direct production costs, measuring the efficiency of cost management and pricing power. This metric assesses the ability of Cybin Inc. (CYBN) to monetize unique molecules under strict DEA oversight, where high costs for clandestine research impact the gross income figure and determine the business's investment attractiveness.